University of California, Davis, School of Medicine, Department of Neurological Surgery, Sacramento, CA, USA; University of Hawai'i at Mānoa, John A. Burns School of Medicine, Honolulu, HI, USA.
University of Hawai'i at Mānoa, John A. Burns School of Medicine, Department of Quantitative Health Sciences, Biostatistics Core Facility, Honolulu, HI, USA.
Clin Neurol Neurosurg. 2023 Oct;233:107841. doi: 10.1016/j.clineuro.2023.107841. Epub 2023 Jun 22.
Hemifacial spasm (HFS) is a disabling condition that imposes significant burden upon patients. Microvascular decompression (MVD) surgery is the most effective and long-lasting treatment for HFS, but outcomes following this surgery may vary based on a variety of clinical and operative factors. A more thorough understanding of the variables that impact patient outcome after MVD surgery is needed.
A systematic review and meta-analysis of Medline, Embase, and Central was conducted (n = 2108 screened; n = 86 included) with the goal of determining the impact of the following variables on outcome: duration of disease, geographic location, intraoperative use of an endoscope, and intraoperative finding of single versus multi-vessel neurovascular compression.
Most cases of hemifacial spasm occur on the left side (53.9%, p < 0.001) and are more common in women than men (66.5% versus 33.5%, p < 0.0001). The offending vessel frequencies were: 40.8% anterior inferior cerebellar artery [AICA], 24.9% posterior inferior cerebellar artery [PICA], 17.2% multiple vessels, and 4.7% vertebral artery [VA]. Multiple vessel combinations involved: 26.5% PICA + AICA, 24.6% PICA + VA, 23.1% AICA + VA, and 4.7% AICA + PICA + VA. Relative to the Americas, AICA was less frequent in Europe (p = 0.005), while PICA more frequent in Europe (p = 0.009) and Asia (p < 0.0001). With endoscope assistance, frequency of multiple vessels identified was 31.7% (versus 14.7% with non-endoscopic, p = 0.005), and 27.4% for AICA (43.5% with non-endoscopic, p = 0.003). Spasm improvement was 94.1% near discharge and 96.0% at maximum follow-up. Complications occurred in 16.5% of cases, with spasm recurrence in 2.4%. Greatest frequency of spasm improvement (p < 0.0001) and lowest spasm recurrence rates (p = 0.0005) were reported in series from Asia. For every additional month of pre-operative spasm, the effect size of post-operative improvement decreased (p = 0.04). With every subsequent postoperative month, the effect size of spasm improvement increased (p = 0.0497). The frequency of spasm improvement was significantly higher in series published after 2005 (94.4% versus 97.4%, p = 0.005).
Clinical outcomes following MVD for HFS have improved since 2005. Consideration should be given to earlier operation (shorter disease duration) and use of an endoscope may increase detection of multiple offending vessels. Further studies are needed to understand regional differences in culprit vessel incidence and surgical outcomes in the Americas, Europe, and Asia.
面肌痉挛(hemifacial spasm,HFS)是一种致残性疾病,会给患者带来严重负担。微血管减压术(microvascular decompression,MVD)是治疗 HFS 最有效和持久的方法,但这种手术的结果可能因各种临床和手术因素而异。需要更深入地了解影响 MVD 手术后患者结局的变量。
对 Medline、Embase 和 Central 进行了系统回顾和荟萃分析(筛选了 2108 篇,纳入了 86 篇),目的是确定以下变量对面神经痉挛结局的影响:疾病持续时间、地理位置、术中使用内窥镜以及术中发现单一血管压迫与多血管压迫。
大多数面肌痉挛发生在左侧(53.9%,p<0.001),且女性比男性更常见(66.5%比 33.5%,p<0.0001)。致病血管的频率为:40.8%为小脑前下动脉(anterior inferior cerebellar artery,AICA),24.9%为小脑后下动脉(posterior inferior cerebellar artery,PICA),17.2%为多血管,4.7%为椎动脉(vertebral artery,VA)。多血管组合涉及:26.5%为 PICA+AICA,24.6%为 PICA+VA,23.1%为 AICA+VA,4.7%为 AICA+PICA+VA。与美洲相比,AICA 在欧洲的频率较低(p=0.005),而 PICA 在欧洲(p=0.009)和亚洲(p<0.0001)的频率较高。使用内窥镜辅助时,识别出的多血管频率为 31.7%(非内窥镜辅助为 14.7%,p=0.005),AICA 为 27.4%(非内窥镜辅助为 43.5%,p=0.003)。出院时的痉挛改善率为 94.1%,最大随访时为 96.0%。16.5%的病例发生并发症,2.4%的病例出现痉挛复发。亚洲系列报告的痉挛改善率最高(p<0.0001),痉挛复发率最低(p=0.0005)。术前痉挛持续时间每增加一个月,术后改善的效果大小就会降低(p=0.04)。随着术后每个月的推移,痉挛改善的效果大小会增加(p=0.0497)。2005 年后发表的系列中,痉挛改善的频率明显更高(94.4%比 97.4%,p=0.005)。
自 2005 年以来,MVD 治疗 HFS 的临床结局有所改善。应考虑更早手术(病程较短),使用内窥镜可能会增加对多个致病血管的检测。需要进一步研究以了解在美洲、欧洲和亚洲,致病血管发生率和手术结果的地区差异。